Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
Overview
TOMI Environmental Solutions Inc. (NASDAQ: TOMZ) is a globally recognized decontamination and infection prevention company that provides innovative environmental solutions focused on indoor surface disinfection. Utilizing its proprietary Binary Ionization Technology (BIT), the company manufactures, sells, and licenses its SteraMist platform of products, which harness a uniquely engineered, low concentration hydrogen peroxide solution. This state‐of‐the‐art technology, developed in collaboration with defense research agencies, has been instrumental in addressing chemical and biological threats, establishing TOMI as a trusted partner in environments where precision, safety, and efficiency are paramount.
Technology and Innovation
The cornerstone of TOMI’s offerings is its patented BIT technology. This innovative process activates and ionizes a 7.8% hydrogen peroxide solution to generate a fine mist or fog of ionized Hydrogen Peroxide (iHP). The resulting aerosol acts as a non‐corrosive, efficient decontaminant that eliminates microorganisms including bacteria, viruses, and fungi. Developed under a defense grant in partnership with agencies such as DARPA, this technology was engineered in response to critical contamination threats and remains unique in its ability to disinfect a range of sensitive materials, from delicate electronics to high-traffic facilities.
Products and Services
The SteraMist brand distinguishes TOMI’s comprehensive product portfolio, which includes systems designed for surface and environmental decontamination. Key products encompass:
- SteraMist Surface Unit – a solution for targeted area decontamination.
- SteraMist Environment System – designed for whole-room or facility-wide disinfection.
- SteraMist Total Disinfection Cart – enabling mobile deployment in diverse settings.
- Custom Engineered Systems (CES) – tailored to meet specific industrial and institutional decontamination requirements.
In addition to manufacturing and direct sales, the company leverages a licensing model for its proprietary technology, thereby establishing a recurring revenue stream and broadening its market reach. The integration of service and training programs ensures that customers consistently achieve optimal disinfection results while adhering to stringent safety protocols.
Industries Served
TOMI’s decontamination solutions are engineered for a broad spectrum of applications. Its products and systems are widely used in:
- Healthcare Facilities: Hospitals, medical centers, and biosafety laboratories that require rigorous infection control.
- Life Sciences and Research: Pharmaceutical labs and research institutions where contamination control is critical.
- Commercial and Institutional Buildings: Office complexes, schools, and universities that benefit from non-corrosive, high-efficiency disinfection.
- Transportation and Public Venues: Cruise ships, sports facilities, and public transportation centers needing rapid, effective sanitation.
- Government and Defense: Facilities that require robust decontamination solutions to address both routine and emergency threats.
Business Model and Value Proposition
TOMI Environmental Solutions operates on a multi-faceted business model that includes direct sales, licensing of its patented BIT technology, and customized service offerings. This diversified approach allows the company to generate recurring revenues while maintaining high margins through its innovative decontamination solutions. The razor/razor-blade model is evident in how the company leverages its foundational BIT technology to drive ongoing services and integration, setting a strong standard in the field of infection prevention.
Market Position and Competitive Landscape
In a competitive environment where effective decontamination is critical, TOMI differentiates itself through its advanced technological platform and a rich history in research-backed innovation. The company has carved out a unique niche by developing a non-corrosive, efficient cleaning solution that minimizes downtime and protects sensitive materials. This is particularly vital in sectors such as healthcare and life sciences, where operational continuity and precision decontamination are non-negotiable. TOMI’s adherence to rigorous safety standards and its capacity to create tailored solutions further reinforce its standing within the market.
Commitment to Quality, Safety, and Compliance
TOMI demonstrably maintains high levels of expertise and trustworthiness through ongoing training programs, comprehensive application protocols, and adherence to industry-specific regulatory standards. The company is associated with multiple professional organizations dedicated to biosafety and infection control, which underscores its commitment to quality and continuous improvement. This robust framework of operational excellence instills confidence in both the efficacy and safety of its decontamination solutions.
Operational Excellence and Global Reach
With a global footprint, TOMI Environmental Solutions has established partnerships with a diverse set of clients, ranging from academic institutions and commercial enterprises to government agencies and military installations. Its emphasis on scalable, customizable systems enables it to address varied decontamination needs across different geographic regions. The company’s proficiency in rapidly deploying technology in response to emergent threats underscores its operational flexibility and technical expertise, ensuring that indoor environments remain safe and contamination-free.
Integrated Research and Development
The continuous evolution of TOMI’s product line is supported by a strong R&D infrastructure dedicated to advancing decontamination technology. By integrating feedback from practical applications in high-stakes environments, the company refines its solutions to enhance performance, safety, and ease of use. This iterative process not only fosters innovation but also solidifies the company’s reputation as an expert in the field of environmental decontamination and infection control.
Overall, TOMI Environmental Solutions stands as a comprehensive provider of decontamination and infection prevention solutions. Its innovative BIT technology and versatile SteraMist platform address the growing need for swift, effective, and safe decontamination across multiple industries. This enduring commitment to technological excellence, operational reliability, and customer-focused innovation positions TOMI as a significant entity within its competitive landscape, catering to stakeholders who value precision, efficiency, and state-of-the-art safety protocols.
By offering reliable, scalable, and innovative decontamination systems, TOMI not only meets current market demands but also continually refines its solutions to address evolving challenges in the realm of infection prevention and environmental safety.
TOMI Environmental Solutions (NASDAQ: TOMZ) has announced an OEM partnership with Pharma Biotech System Components (PBSC) to enhance its SteraMist Integrated System (SIS) product line. Through this collaboration, TOMI will offer pass-through hatches and chambers integrated with iHP technology for optimized decontamination cycles.
PBSC, a leading manufacturer of cleanroom and high containment solutions, serves pharmaceutical, medical research, and hospital sectors worldwide. The partnership leverages PBSC's expertise in high-containment enclosures while expanding SteraMist adoption in critical industries. Several projects are currently in progress, demonstrating strong market demand for this innovative system.
The partnership enhances TOMI's Binary Ionization Technology® (BIT™) platform, which uses low percentage hydrogen peroxide and patented ionized Hydrogen Peroxide (iHP™) technology for superior disinfection across various sectors including hospitals, biosafety labs, and pharmaceutical facilities.
TOMI Environmental Solutions (NASDAQ: TOMZ) has secured a significant $450,000 contract to install a SteraMist iHP Custom Engineered System (CES) at a leading Rhode Island university. The contract, secured through distributor ARES Distribution, demonstrates TOMI's competitive edge over hydrogen peroxide competitors.
The company is also in negotiations with a long-standing Boston client for a CES upgrade and expansion project. Earlier this quarter, TOMI added a SteraPak system sale at a Massachusetts private university. The company's New England territory portfolio now includes over 20 biotechnology, pharmaceutical, and research university customers.
TOMI's Binary Ionization Technology® (BIT™) platform, originally developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP™) technology for superior disinfection and decontamination solutions.
TOMI Environmental Solutions (NASDAQ: TOMZ) has successfully implemented its SteraMist technology at Algafeed, a company specializing in large-scale microalgae production for aquaculture. The partnership addresses Algafeed's challenge with Protozoan ciliate contamination in algae cultivation.
The implementation has effectively reduced ciliate contamination to levels that no longer impact target production volumes. Algafeed's innovative technology enables the cultivation and delivery of high-density microalgae, serving as a primary food source for shrimp, shellfish, and finfish farms.
SteraMist technology, developed under a DARPA defense grant, uses Binary Ionization Technology® (BIT™) platform with low percentage hydrogen peroxide as its active ingredient. The successful implementation demonstrates TOMI's ability to expand into the aquaculture sector while providing effective contamination solutions.
TOMI Environmental Solutions (NASDAQ: TOMZ) has announced the deployment of its SteraMist iHP technology at the NASA Johnson Space Center, marking its entry into the aerospace sector. The technology, developed through DARPA, will be used in a biosafety cabinet for handling Mars Perseverance Rover mission samples.
The deployment, facilitated through TOMI's distributor ARES Distribution, is in the final qualification process and has shown promising results in meeting NASA's planetary protection requirements. This initiative is part of TOMI's SteraMistX campaign, which focuses on aerospace, military, and exploration fields.
The company's Binary Ionization Technology® (BIT™) platform uses a low percentage hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems for superior disinfection.
TOMI Environmental Solutions (NASDAQ: TOMZ), a global disinfection and decontamination company, has announced its participation in the upcoming Q1 Investor Summit Event. Dr. Halden Shane, Chairman and CEO, will present virtually on March 11, 2025, at 10:30 am Eastern Time.
The company specializes in Binary Ionization Technology (BIT) platform through its SteraMist products. The technology, developed under a defense grant with DARPA, uses ionized Hydrogen Peroxide (iHP) technology with a low percentage hydrogen peroxide as its active ingredient.
TOMI's disinfection solutions serve diverse sectors including:
- Hospitals and medical facilities
- Biosafety labs
- Pharmaceutical facilities
- Commercial buildings
- Schools
- Restaurants
- Meat and produce processing facilities
- Police and fire departments
TOMI Environmental Solutions (NASDAQ: TOMZ) has achieved compliance with Avetta, a third-party vendor management and compliance platform, demonstrating its commitment to health, safety, and environmental (HSE) excellence. This achievement complements TOMI's existing memberships with Highwire and ISNetworld.
The company specializes in disinfection and decontamination solutions through its Binary Ionization Technology® (BIT™) platform, which was developed under a defense grant with DARPA. The technology uses low percentage hydrogen peroxide and patented ionized Hydrogen Peroxide (iHP™) technology in SteraMist systems.
According to COO Elissa J. Shane, this compliance validation enhances TOMI's credibility with platinum life sciences customers and is expected to drive revenue growth. The company's solutions serve various sectors, including hospitals, biosafety labs, pharmaceutical facilities, commercial buildings, schools, and food processing facilities.
TOMI Environmental Solutions (NASDAQ: TOMZ) reported significant revenue growth in January 2025. The company's BIT Solution sales increased by 159% compared to January 2024, while its iHP Corporate Service revenue showed an 89% increase in completed services for the same period.
Dr. Halden Shane, CEO, highlighted increased customer engagement and growing recognition of their disinfection technology. The company noted positive shifts in customer behavior, with key decision-makers establishing formal project timelines for larger-scale initiatives. Management expects strong revenue performance to continue throughout 2025.
These results are preliminary and subject to adjustments pending the completion of Q1 2025 financial closing processes.
TOMI Environmental Solutions (NASDAQ: TOMZ) has successfully regained compliance with Nasdaq's minimum bid price requirement as of January 14, 2025, after maintaining a closing bid price of $1.00 or higher for 10 consecutive trading days. The company will continue trading on The Nasdaq Capital Market under the symbol 'TOMZ'.
Building on its 2024 achievements, TOMI outlined its 2025 growth strategy focusing on: expanding partnerships in high-growth markets including government, commercial, and educational sectors; innovating its SteraMist technology; targeting international expansion to address global infectious disease concerns; and maintaining operational and financial excellence.
The company specializes in disinfection and decontamination solutions through its Binary Ionization Technology® (BIT™) platform, which uses ionized Hydrogen Peroxide (iHP™) technology developed under a DARPA defense grant.
TOMI Environmental Solutions (NASDAQ: TOMZ) announces its readiness to address emerging public health threats using its SteraMist technology amid growing concerns over RSV, HMPV, and H5N1 viruses. The company is expanding its reach to government agencies, commercial clients, and school districts nationwide.
Building on its track record in controlling previous pandemics like Ebola and SARS-CoV-2, TOMI is positioned to meet increasing demand for infection prevention solutions. The company secured new contracts with school districts and is collaborating with distributors as global infectious disease threats intensify, including the HMPV surge in China and ongoing avian flu outbreak.
With the U.S. Department of Health and Human Services allocating $306 million for avian flu response, TOMI's technology is well-suited for high-risk environments. The company's SteraMist solution, which uses ionized Hydrogen Peroxide technology, leaves no harmful residues and is environmentally friendly, making it suitable for various applications including healthcare facilities, schools, and food production facilities.
TOMI Environmental Solutions (NASDAQ: TOMZ) has announced a new installation of its Custom Engineered Solution (CES) at a pharmaceutical facility in the United Kingdom. The facility is investing $500,000 in a twelve-applicator CES system that utilizes SteraMist iHP technology for efficient decontamination without requiring complete facility shutdowns.
The installation represents TOMI's strategic expansion in critical markets through its innovative technology offerings. The SteraMist technology uses Binary Ionization Technology (BIT) platform, which was developed under a defense grant with DARPA and employs low percentage hydrogen peroxide as its active ingredient to create ionized Hydrogen Peroxide (iHP) for superior disinfection.
FAQ
What is the current stock price of Tomi Environmental Solutions I (TOMZ)?
What is the market cap of Tomi Environmental Solutions I (TOMZ)?
What does TOMI Environmental Solutions specialize in?
How does the BIT technology work?
Which industries are served by TOMI's products?
What differentiates TOMI's decontamination solutions from other products?
How does TOMI generate revenue?
What are the key features of the SteraMist product line?
In what ways has TOMI established its credibility in the industry?
What are the benefits of TOMI's customizable solutions?
